Citation Impact
Citing Papers
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Defining the clinical course of multiple sclerosis
1996 Standout
Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
1990
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
2016 Standout
Surgical prognosis of unruptured intracranial arterial aneurysms
1987
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
2001
The natural history of multiple sclerosis:a geographically based study
1999
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis
2008 Standout
Prognostic factors for the progression of Parkinson's disease: A systematic review
2007
Vaccinations and the Risk of Relapse in Multiple Sclerosis
2001
Rheumatoid arthritis
2018 Standout
The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease
2006
Sjögren's syndrome
2005 Standout
The spectrum of neuromyelitis optica
2007 Standout
Natural history of multiple sclerosis: a unifying concept
2006
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
The precuneus: a review of its functional anatomy and behavioural correlates
2006 Standout
HLA-DM polymorphisms do not associate with multiple sclerosis: an association study with analysis of myelin basic protein T cell specificity
1997
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
1993 Standout
The Clinical Epidemiology of Multiple Sclerosis
2008
Parkinson's disease: clinical features and diagnosis
2008 Standout
Pure Topographical Disorientation Related to Dysfunction of the Viewpoint Dependent Visual System
1998
Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis
1995
Cognitive impairment in multiple sclerosis
2008 Standout
Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis
1997
Natural history of multiple sclerosis
2005
A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis
2002
Natural History of Multiple Sclerosis Symptoms
2013 Standout
The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure
2001 Standout
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France
1989
Multiple sclerosis
2008 Standout
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
1999
Frequency of MS in the province of Modena, 1970-1990
2009
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
2012
Immunopathology of multiple sclerosis
2015 Standout
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
1994
A cortical representation of the local visual environment
1998 StandoutNature
Gender differences in autoimmune disease
2014
Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden
1990
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
2004 Standout
Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six months
1989
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
1998 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Robot-based rehabilitation of the upper limbs in multiple sclerosis: Feasibility and preliminary results
2009
Age at disability milestones in multiple sclerosis
2006
HLA class II‐associated genetic susceptibility in multiple sclerosis: A critical evaluation
1991
Sex differences in autoimmune disease
2001 Standout
Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data
2007
Multiple Sclerosis
2000 Standout
Helping others helps oneself: response shift effects in peer support
1999
The influence of pregnancy on relapses in multiple sclerosis: a cohort study
1991
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
2011 Standout
Sex ratio of multiple sclerosis in Canada: a longitudinal study
2006
Relapses and Progression of Disability in Multiple Sclerosis
2000
Hyperbaric oxygen for multiple sclerosis
1995
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 Standout
Major differences in the dynamics of primary and secondary progressive multiple sclerosis
1991
A survey on robotic devices for upper limb rehabilitation
2014 Standout
Natural History of Multiple Sclerosis with Childhood Onset
2007
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Multiple sclerosis
2002 Standout
Primary Sjögren's Syndrome with Central Nervous System Disease Mimicking Multiple Sclerosis
1986
The Complex Role of Estrogens in Inflammation
2007 Standout
Knowing Where Things Are: Parahippocampal Involvement in Encoding Object Locations in Virtual Large-Scale Space
1998 StandoutNobel
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
The Natural History of Multiple Sclerosis
1995
Polymyositis and Dermatomyositis
1975 Standout
EDMUS, a European database for multiple sclerosis.
1992
Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.
1995
Osmotic Demyelination Syndrome Following Correction of Hyponatremia
1986 Standout
Serial Evoked Potential Studies in Patients With Definite Multiple Sclerosis
1984
Neuropsychology of multiple sclerosis: A critical review
1986
Gait Analysis Methods: An Overview of Wearable and Non-Wearable Systems, Highlighting Clinical Applications
2014 Standout
Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis
1981 Science
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
1987
Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients.
1959
Evaluating non-randomised intervention studies
2003 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Recommendations for the clinical use of somatosensory-evoked potentials
2008 Standout
Epidemiology of multiple sclerosis in Australia: With NSW and SA survey results
1994
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
2009
Loss of Topographic Familiarity
1986
The clinical course of neuromyelitis optica (Devic’s syndrome)
1999 Standout
Rapid Evolution of RNA Genomes
1982 StandoutScience
The natural history of multiple sclerosis: a regional study with some longitudinal data.
1992
Quality of life in multiple sclerosis
1999
Unruptured Intracranial Aneurysms — Risk of Rupture and Risks of Surgical Intervention
1998 Standout
Muscle Involvement in Sarcoidosis
1969
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
2010 Standout
Providing Social Support May Be More Beneficial Than Receiving It
2003 Standout
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
2004
Longitudinal follow-up of “benign” multiple sclerosis at 20 years
2007
Syndromes majeurs de l'hémisphère mineur
2005
Multivariate analyses of factors associated with unemployment in people with multiple sclerosis.
1990
Association of the APOE epsilon 4 allele with disease activity in multiple sclerosis
1999
Works of M Devic being referenced
[Case of Besnier-Boeck nodular myositis].
1955
Course of visual evoked potentials in multiple sclerosis: electroclinical correlations and pathophysiological considerations in 25 patients.
1982
[Ineffectiveness of hyperbaric oxygen therapy in multiple sclerosis. A randomized placebo-controlled double-blind study].
1986
Une Observation Anatomo-Clinique De Fabulation (Ou Délire) Topografique
1980
Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon.
1986
[Terminologic, etiologic, anatomic and clinical considerations on Gayet-Wernicke encephalopathy; relations with Marchiafava-Bignami syndrome and Korsakoff's syndrome].
1953
[Parkinson's disease. Retrospective study of 302 clinical case records].
1984
[Non-hemorrhagic forms of intracranial arterial aneurysms].
1980
[South-Eastern France, a high risk area for multiple sclerosis?].
1987
MULTIPLE SCLEROSIS WITH HYPOCOMPLEMENTÆMIA
1975
COURSE AND PROGNOSIS OF MULTIPLE SCLEROSIS ASSESSED BY THE COMPUTERIZED DATA PROCESSING OF 349 PATIENTS
1980